Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients

Although immunotherapy is already a staple of cancer care, many patients may not benefit from these cutting-edge treatments. A crucial field of research now focuses on figuring out how to improve treatment efficacy and assess the resistance mechanisms underlying this uneven response. For a good resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Allegra, Alessandro, Murdaca, Giuseppe, Mirabile, Giuseppe, Gangemi, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215686/
https://www.ncbi.nlm.nih.gov/pubmed/37238995
http://dx.doi.org/10.3390/biomedicines11051325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215686/
https://www.ncbi.nlm.nih.gov/pubmed/37238995
http://dx.doi.org/10.3390/biomedicines11051325

Ejemplares similares